← Search

Data · dataset · 2026

Molecular cloning, peptide synthesis and bioactive assessment of a skin defensive peptide, QUB-2658 from the skin secretion of <i>Limnonectes fujianensis</i>

Listed in ZivaHub and Deakin Research Online and DMU Figshare and UCL Research Data Repository — shown once because both records carry DOI 10.17034/32629983.v1

In recent years, research on amphibian skin secretion peptides has become a hot topic for researchers.

Description

Antimicrobial peptides (AMPs) from amphibian skin secretion were found to have excellent broad-spectrum antibacterial activities and inhibit drug-resistant bacteria, which made AMPs a potential new antibacterial drug source. Frog skin secretions are the most abundant source of AMPs and thus they have been widely studied by researchers. <br><br>In this study, a novel peptide (with an 훼-helix structure) named QUB-2658 (ANMFEDLKNVIKLVEQDRPVLSV-NH2) which does not belong to any known peptide family, has been isolated from the skin secretion of Limnonectes fujianensis.

From the same skin secretion, a cDNA library was constructed and subjected to RACE-PCR. The peptide biosynthetic precursor-encoding cDNA sequence was obtained using molecular cloning and Sanger Sequencing. The mature peptide was synthesized by solid phase peptide synthesis, identified and purified by MALDI-TOF mass spectrometry and reverse phase High Performance Liquid Chromatography.

Read the rest (1 more)

Data from antibacterial and anticancer assays showed that the peptide exhibited weak antibacterial activity against S. aureus and E. coli with around 10% inhibition rate at the highest concentration of 512 µM. Additionally, QUB-2658 showed no activity against C. albicans as well as two cancer cell lines, U251-MG and HTC-116, at the highest concentrations. Similarly, it exerted no haemolytic activity with the haemolysis is 5.7% at 512 µM. In future work, modification can try to change specific residues to produce a hydrophobic surface in QUB-2658 with the aim to improve the amphiphilic property of the peptide and maybe its antibacterial activity.

Links

Where it is published

Catalogue records · 1

Topics

Inferred from text
Cancer 75% · Mass spectrometry 75% · Sequencing 75%
Provenance · 4 source records, 11 field assertions
SourceKeyLast seenRaw
ZivaHuboai:figshare.com:article/3262998312 d agoJSON v1
Deakin Research Onlineoai:figshare.com:article/3262998312 d agoJSON v1
DMU Figshareoai:figshare.com:article/3262998312 d agoJSON v1
UCL Research Data Repositoryoai:figshare.com:article/3262998312 d agoJSON v1
FieldAssertionExtractorEvidence
concepts[disease].local:disease:cancerenrichment · zivahub uct ac zakeyword-concept-rules@1.0.0title+description (75%)
concepts[field].local:field:earth-environmentalmapping · dro deakin edu auconnector:dro_deakin_edu_au@1.0.0
concepts[field].local:field:earth-environmentalmapping · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0
concepts[field].local:field:earth-environmentalmapping · figshare dmu ac ukconnector:figshare_dmu_ac_uk@1.0.0
concepts[field].local:field:earth-environmentalmapping · rdr ucl ac ukconnector:rdr_ucl_ac_uk@1.0.0
concepts[modality].local:modality:mass-spectrometryenrichment · zivahub uct ac zakeyword-concept-rules@1.0.0title+description (75%)
concepts[modality].local:modality:sequencingenrichment · zivahub uct ac zakeyword-concept-rules@1.0.0title+description (75%)
descriptionsource · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0/metadata/dc/description
license_textsource · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0
publication_datesource · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0
titlesource · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0/metadata/dc/title